Medline Stock Plunges 13% on Product Quality Issues, Securities Fraud Probe
Medline Industries' stock experienced a significant decline of 13% following disclosures of product quality issues. A securities fraud investigation has been initiated.
Medline Industries' stock experienced a significant decline of 13% following disclosures of product quality issues. A securities fraud investigation has been initiated.